<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Immunocytochemistry on Leukoformula</title><link>https://www.leukoformula.com/en/tags/immunocitohimiya/</link><description>Recent content in Immunocytochemistry on Leukoformula</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Wed, 07 Aug 2024 19:30:00 +0300</lastBuildDate><atom:link href="https://www.leukoformula.com/en/tags/immunocitohimiya/feed.xml" rel="self" type="application/rss+xml"/><item><title>p16 Marker in Immunocytochemistry of Cervical Neoplasms</title><link>https://www.leukoformula.com/en/post/marker-p16-v-immunocitohimii-novoobrazovaniy-2293/</link><pubDate>Wed, 07 Aug 2024 19:30:00 +0300</pubDate><guid>https://www.leukoformula.com/en/post/marker-p16-v-immunocitohimii-novoobrazovaniy-2293/</guid><description>&lt;p>🔬 p16 Marker. Immunocytochemistry of Cervical Neoplasms. Educational material from the Department of Clinical Laboratory Diagnostics, RMACPE.&lt;/p>
&lt;ul>
&lt;li>detected in the cytoplasm&lt;/li>
&lt;li>kinase blocker, activating cell DNA synthesis&lt;/li>
&lt;li>corresponds to the level of high-risk HPV E7 oncoprotein&lt;/li>
&lt;li>Detected in dysplasia: CIN I in 30-60%, CIN II in 80-100%, CIN III up to 100%&lt;/li>
&lt;/ul>
&lt;p>💎 Find more useful materials on cytology in our &lt;a href="https://vk.com/@labformula-lab-test-library" target="_blank" rel="noopener nofollow ugc">LAB-TESTS&lt;span class="link-ext" aria-hidden="true">↗&lt;/span>&lt;/a> library. The link with access to the library is automatically sent to you via private message after paying for a &lt;a href="https://vk.com/donut/labformula" target="_blank" rel="noopener nofollow ugc">VK donut Labformula&lt;span class="link-ext" aria-hidden="true">↗&lt;/span>&lt;/a> subscription.&lt;/p></description></item></channel></rss>